Armistice Capital’s Can-Fite BioPharma CANF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-650,000
| Closed | -$1.31M | – | 240 |
|
|
2024
Q3 | $1.31M | Buy |
650,000
+131,147
| +25% | +$264K | 0.02% | 162 |
|
|
2024
Q2 | $1.34M | Buy |
518,853
+136,055
| +36% | +$351K | 0.02% | 153 |
|
|
2024
Q1 | $850K | Buy |
382,798
+228,435
| +148% | +$507K | 0.01% | 168 |
|
|
2023
Q4 | $340K | Buy |
+154,363
| New | +$340K | ﹤0.01% | 212 |
|
|
2023
Q2 | – | Sell |
-330,000
| Closed | -$756K | – | 228 |
|
|
2023
Q1 | $756K | Buy |
+330,000
| New | +$756K | 0.01% | 144 |
|
|
2021
Q4 | – | Sell |
-87,500
| Closed | -$1.45M | – | 149 |
|
|
2021
Q3 | $1.45M | Buy |
+87,500
| New | +$1.45M | 0.02% | 119 |
|